O'PKA SIL KASALLIKLARI VA BOG'LIQ PATOLOGIYALAR – KOMORBIDLIK, PATOGENEZ VA BEMORLARNI BOSHQARISH MUAMMOLARI
##article.subject##:
sil, hamroh kasalliklar, atipik kechish##article.abstract##
Sil (TB) butun dunyo bo'ylab yuqumli kasalliklardan o'limning asosiy sabablaridan biri bo'lib qolmoqda. Hozirgi tadqiqotlar o'pka silining natijasi va epidemiologiyasi komorbidliklarning mavjudligi bilan uzviy bog'liqligini ishonchli tarzda ko'rsatadi. Ushbu sharhda sil kasalligidagi asosiy komorbid holatlar, ularning patogenezi, tashxisi, davolashi va kasallik natijalariga ta'siri o'rganiladi va ushbu bemorlarni davolashga kompleks yondashuv zarurligi ta'kidlanadi.
Библиографические ссылки
Lönnroth K., et al. (2015). A framework for collaborative action on tuberculosis and comorbidities. The European Respiratory Journal , 45(1), 1–4.
Pawlowski A., et al. (2012). Tuberculosis and HIV co-infection. PLoS Pathogens , 8(2), e1002464.
World Health Organization. (2021). Consolidated guidelines on tuberculosis: Module 4: Treatment: Drug-resistant tuberculosis treatment.
Restrepo B.I. (2016). Diabetes and Tuberculosis. Microbiology Spectrum , 4(6).
Degner N.R., et al. (2018). Metformin use reverses the increased mortality associated with diabetes mellitus during tuberculosis treatment. Clinical Infectious Diseases , 66(2), 198–205.
Byrne A.L., et al. (2015). Tuberculosis and chronic respiratory disease: a systematic review. International Journal of Infectious Diseases , 32, 138–146.
Dobler C.C., et al. (2017). Burden of tuberculosis and serious comorbidities: a retrospective matched cohort study. BMC Infectious Diseases , 17, 112.
Tiberi S., et al. (2018). Managing tuberculosis and liver disease. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases , 13, 1–6.
Tuberculosis and chronic respiratory disease: a systematic review, Anthony L Byrne 1, Ben J Marais 2, Carole D Mitnick 3, Leonid Lecca 4, Guy B Marks 5
Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD). Janjua S, Carter D, Threapleton CJ, Prigmore S, Disler RT. Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD013196.
Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease. Chong J, Karner C, Poole P. Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009157.
Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis. Janjua S, Mathioudakis AG, Fortescue R, Walker RA, Sharif S, Threapleton CJ, Dias S. Cochrane Database Syst Rev. 2021 Jan 15;1(1):CD013198.
Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD). Janjua S, Pike KC, Carr R, Coles A, Fortescue R, Batavia M. Cochrane Database Syst Rev. 2021 Sep 8;9(9):CD013381.
